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Atrial natr iuretic factor (ANF) N-terminal (ANF 1-98) and C- 
terminal (ANF 99-126) fragments were determined by 
radioimmunoassay in human plasma. Mean basal plasma ANF N- 
terminal concentrations in 9 healthy subjects were 461 + 58 
fmol/ml, s ignif icantly (p<0. 0001) higher than ANF C-terminal 
concentrations ( 4.8 + 0.5 fmol/ml). Central volume stimulation 
by one hour head-out water immersion (WI) induced a signif icant 
(p<0.01) increase of the C-terminal peptide levels to 11.6 + 
2.3 fmol/ml,paral leled by a signif icant (p<0.001) increase of 
the N-terminal fragment levels to 749 + 96 fmol/ml. Increases 
of plasma concentrations of both fragments upon WI correlated 
signif icantly (r=0.71;p<0.05). These data suggest cosecretion 
of the N-terminal fragment with the C-terminal fragment of pro 
ANF 1-126 fol lowing a physiological stimulus of ANF release in 
man. ® 1988 Academic  Press, Inc. 
Atrial natr iuretic factor (ANF) is stored in atrial granules as 
126 amino acid prohormone (for review, see i). Upon appropriate 
st imulat ion,such as atrial stretch (2), it is released and 
cleaved, and in the plasma the biological ly active form has 
been identif ied as the 28 amino acid C-terminal fragment ANF 
99-126 (3-7). Recently,presence of the N-terminal fragment ANF 
1-98 has also been demonstrated in plasma of both,rat and man 
(8,9). This finding together with the observation of increased 
concentrations of both, N-terminal and C-terminal 
immunoreactivity following morphine st imulation in rats, 
suggested cosecretion of both fragments (8,9). The present 
study addresses the issue of cosecretion in man,applying water 
immersion (WI) as a physiological stimulus of ANF release (i0- 
12). 
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MATERIALS  AND METHODS 
Subjects  
9 hea l thy  subjects,  5 men and 4 women, aged 30 to 65 (mean 47 ± 
3) years  were  invest igated af ter  the i r  in formed consent  had 
been obtained.  The subjects  had a normal  phys ica l  examinat ion  
and normal  rout ine laboratory  tests. They showed no ev idence  of 
card iovascu lar , rena l ,pu lmonary  or endocr ine  d iseases.  The 
subjects  were  on a regular  d ie t , conta in ing  approx imate ly  150 
meq sodium and took no medicat ions.  
Water  immers ion 
The protoco l l  has been spec i f ied before  (10,12) .Br ief ly :  In the 
morn ing  of the exper iment ,an  in t ravenous  catheter  was p laced 
into a forearm vein and sub jects  sat down comfor tab ly  on a 
chai r  next  to the immers ion tank. A f ter  1 hour , they  were  
immersed to the i r  neck into thermoneut ra l  (34.5 ± 0.2 °C) water  
for one hour ,ma inta in ing  the same seated posi t ion.  Th is  was 
fo l lowed by a 1 hour  per iod  of s i t t ing  outs ide the tank. P lasma 
samples were co l lected before ,after 1 hour  WI and 1 hour  
af ter  the end of WI. 
Determinat ion  of ANF by rad io immunoassay  
C- termina l  ANF was determined by RIA, us ing  ant i serum Toni  
I I I ,as  descr ibed  in detai l  be fore  (6). The R IA  procedure  for 
the N- termina l  f ragment wi th  ant ibody  GT 23 has been repor ted  
e lsewhere  in detai l  (9). 
Chromatoqraph ic  analys is  of ANF immunoreact iv i ty  (ir) 
Serum was app l ied  to a Spherogel  TM TSK, 2000 SW co lumn (i0 
m,7.5  mm x 300 mm;Beckman Ins t ruments ,San  Ramon,Ca. ,USA)  and 
e luted wi th  0.09 % TFA conta in ing  0.005 M Na2SO4,0 .002  M 
NaH2PO 4 and 30% acetoni t r i le ;  f lowrate was 0.3 ml/min.  
Ca l ib ra t ion  of the co lumn was per fo rmed wi th  bov ine  serum 
a lbumin ,MW 66 KD (Vo) , cytochrome C,MW 12.5 KD, v i tamin  B 12, 
MW 0.7 KD (Vt) , rat pro ANF 2-126,MW 15 KD and human ANF 99- 
126,MW 3 KD. Fract ions  (0.3 ml) were  lyoph i l i zed  and tes ted  for 
ir ANF by both  RIA procedures.  
S tat i s t i ca l  eva luat ion  
D i f fe rences  between N- termina l  and C- termina l  concent ra t ions  as 
wel l  as concent ra t ions  of the same f ragment  be fore  and af ter  WI 
were  compared by pa i red  t-test.  The Pearson  cor re la t ion  
coef f i c ient  was determined by the usual  l inear  least  squares 
test. Data are presented  as mean and s tandard  error. 
RESULTS AND DISCUSSION 
Concent ra t ions  and HPLC analys is  of N - termina l  and C- termina l  
immunoreact iv i ty  in human p lasma 
The mean p lasma concent ra t ion  of the N- termina l  f ragment  in 
basal  cond i t ions  was s ign i f i cant ly  (p<0.0001) h igher  than the 
mean concent ra t ion  of C- terminal  ANF: 461 ± 58 fmol /ml  as 
compared to 4.8 ± 0.5 fmol/ml. This  f ind ing is in accordance  
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Figure 1 
HPLC analysis of C-terminal (panel A) and N-terminal (panel B) 
ANF immunoreactivity. 
The void (Vo)  and total volumes (Vt) of the column were 
determined by BSA and vitamin B 12, respectively. Arrows 
indicate the elution positions of rat pro ANF 2-126, cytochrome 
C and human ANF 99-126. C-terminal immunoreactivity elutes in 
the molecular weight range of ANF 99-126, N-terminal 
immunoreactivity in the range of ANF 1-98. 
w i th  recent  observat ions  (9) and may be due to a longer 
e l im inat ion  ha l f - l i fe  of the N- te rmina l  f ragment.  
F igure  1 shows a HPGPC ana lys is  of C - termina l  (panel A) and N- 
termina l  (panel B) ANF immunoreact iv i ty .  The C- termina l  ir was 
detected  as a s ing le  peak coe lu t ing  wi th  synthet ic  ANF 99-126. 
The N- termina l  ir was e luted as a s ingle  peak  in the molecu la r  
we ight  range of ANF 1-98. 
N - te rmina l  and C- termina l  p lasma concent ra t ions  after  
s t imu la t ion  of ANF re lease 
Fo l low ing  immers ion  p lasma concent ra t ions  of C - termina l  ANF 
increased s ign i f i cant ly  (p<0.01) from 4.8 ± 0.5 fmol /ml  to 11.6 
± 2.3 fmo l /ml , re turn ing  to 5.7 ± 0.7 fmol /ml  post  immers ion 
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Figure 2 
Plasma concentrations of C-terminal and N-terminal ANF 
immunoreactivity after stimulation of ANF release. 
Plasma concentrations (mean ± standard error) of C-terminal 
(panel A) and N-terminal (panel B) ANF immunoreactivity before 
("Pre"), after one hour water immersion ("Immersion") and one 
hour after the end of water immersion ("Post") of nine healthy 
subjects. Immersion induced a significant (p<0.01) increase of 
both, C-terminal and N-terminal ANF. 
(figure 2a). This finding is in accordance with previous 
observations of our (10,12) and of other groups (11,13-15) and 
supports the contention that central volume stimulation 
stimulates ANF release. Interestingly,the concentration of the 
counterpar t  of the C-terminal  f ragment , the  N- termina l  f ragment  
a lso was found increased upon immersion: p lasma levels  rose 
f rom 461 ± 58 fmol /ml  to 749 ± 96 fmol /ml  (p<0.001) dur ing  
WI , re turn ing  to 590 ± 83 fmol/ml in the recovery  per iod  (f igure 
2b). The augmentat ions  of p lasma concent ra t ion  of both  
f ragments  by immers ion were  cor re la ted  s ign i f i cant ly  
(r=0.71,p<0.05).  
The observat ion  of an increase of the N- termina l  in para l le l  
w i th  the C- termina l  f ragment of pro ANF 1-126 suggests  
cosecret ion  of both pept ides  in man fo l lowing a phys io log ica l  
s t imulus  of ANF release. 
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